JP2024536146A5 - - Google Patents
Info
- Publication number
- JP2024536146A5 JP2024536146A5 JP2024519313A JP2024519313A JP2024536146A5 JP 2024536146 A5 JP2024536146 A5 JP 2024536146A5 JP 2024519313 A JP2024519313 A JP 2024519313A JP 2024519313 A JP2024519313 A JP 2024519313A JP 2024536146 A5 JP2024536146 A5 JP 2024536146A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163251562P | 2021-10-01 | 2021-10-01 | |
| US63/251,562 | 2021-10-01 | ||
| US202163287960P | 2021-12-09 | 2021-12-09 | |
| US63/287,960 | 2021-12-09 | ||
| PCT/US2022/077389 WO2023056446A1 (en) | 2021-10-01 | 2022-09-30 | Angiotensinogen-modulating compositions and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024536146A JP2024536146A (ja) | 2024-10-04 |
| JP2024536146A5 true JP2024536146A5 (https=) | 2025-10-07 |
| JPWO2023056446A5 JPWO2023056446A5 (https=) | 2025-10-07 |
Family
ID=85783681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024519313A Pending JP2024536146A (ja) | 2021-10-01 | 2022-09-30 | アンジオテンシノーゲンを調節する組成物及びその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240401045A1 (https=) |
| EP (1) | EP4408525A4 (https=) |
| JP (1) | JP2024536146A (https=) |
| KR (1) | KR20240099244A (https=) |
| AU (1) | AU2022355198A1 (https=) |
| CA (1) | CA3233330A1 (https=) |
| WO (1) | WO2023056446A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL312811A (en) | 2021-11-16 | 2024-07-01 | Shanghai Argo Biopharmaceutical Co Ltd | Composition and method for inhibiting angiotensinogen (agt) protein expression |
| PE20241340A1 (es) * | 2021-11-24 | 2024-07-03 | Adarx Pharmaceuticals Inc | Composiciones moduladoras de complemento del factor b y metodos de uso de estas |
| WO2025024283A1 (en) * | 2023-07-21 | 2025-01-30 | Adarx Pharmaceuticals, Inc. | Coagulation factor xi-modulating compositions and methods of use thereof |
| CN119876130A (zh) * | 2023-10-23 | 2025-04-25 | 广东东阳光药业股份有限公司 | 一种新型的双链siRNA、其缀合物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3215908A1 (en) * | 2014-05-22 | 2015-11-26 | Alnylam Pharmaceuticals, Inc. | Angiotensinogen (agt) irna compositions and methods of use thereof |
| CN113817735A (zh) * | 2015-10-08 | 2021-12-21 | Ionis制药公司 | 用于调节血管紧张素原表达的化合物和方法 |
| TWI851574B (zh) * | 2018-05-14 | 2024-08-11 | 美商阿尼拉製藥公司 | 血管收縮素原（ＡＧＴ）ｉＲＮＡ組成物及其使用方法 |
| WO2022221457A1 (en) * | 2021-04-13 | 2022-10-20 | Adarx Pharmaceuticals, Inc. | Rna silencing agents and methods of use |
| TW202405171A (zh) * | 2022-04-01 | 2024-02-01 | 美商雅迪克斯製藥公司 | 血管收縮素原調節組合物及其使用方法 |
-
2022
- 2022-09-30 US US18/697,165 patent/US20240401045A1/en active Pending
- 2022-09-30 EP EP22877626.6A patent/EP4408525A4/en active Pending
- 2022-09-30 WO PCT/US2022/077389 patent/WO2023056446A1/en not_active Ceased
- 2022-09-30 AU AU2022355198A patent/AU2022355198A1/en active Pending
- 2022-09-30 JP JP2024519313A patent/JP2024536146A/ja active Pending
- 2022-09-30 CA CA3233330A patent/CA3233330A1/en active Pending
- 2022-09-30 KR KR1020247014615A patent/KR20240099244A/ko active Pending